XHKG
0030
Market cap266mUSD
Oct 09, Last price
0.21HKD
1D
-5.41%
1Q
-22.22%
Jan 2017
61.54%
Name
Ban Loong Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
YNBY International Ltd. operates as an investment holding company, conducting business primarily in money lending and the global trade of various goods and commodities across Hong Kong, the People's Republic of China, and international territories. The firm's operations are divided into distinct segments: Money Lending, Trading of Goods and Commodities, and Cannabidiol (CBD) isolate. In its financial services arm, the company offers short-term loans to both private individuals and corporate entities. Its trading activities encompass a diverse portfolio, including refined edible oil, sugar, cosmetics, cannabidiol, and personal care products. Moreover, YNBY International has established a strategic partnership with Alpex Pharma SA to jointly advance the development and commercialization of nutraceuticals. Located in Wan Chai, Hong Kong, the company adopted its current name after previously operating as ABC Communications (Holdings) Limited and subsequently as Ban Loong Holdings Limited, a change that occurred in October 2015.
Key people
Ming Dong
Executive Chairman of the Board · since 2022
Wang Chow
Executive Deputy Chairman of the Board · since 2022
Huaiyu Liu
Chief Financial Officer, Executive Director · since 2025
Zhouyang Liu
Executive Director · since 2022
Ming Tang
Chief Executive Officer, Executive Director · since 2022
Zhaoqing Wang
Chief Operating Officer, Executive Director · since 2017
Tao He
Non-Executive Director · since 2025
Non-Executive Director · since 2022
Non-Executive Director · since 2022
Wai Bing Pang
Independent Non-Executive Director · since 2023
Independent Non-Executive Director · since 2023
Cheung Hoi Yu
Independent Non-Executive Director · since 2023
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||